根據 位華爾街分析師的預測,RBC Life Sciences Inc 的收入預期範圍從 $ 到 $
RBC Life Sciences Inc 的盈利品質評分是多少?
RBC Life Sciences Inc 的盈利品質評分為 B/43.893513。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
RBC Life Sciences Inc 何時發布財報?
RBC Life Sciences Inc 的下一份財報預計在 發布
RBC Life Sciences Inc 的預期收益是多少?
根據華爾街分析師的預測,RBC Life Sciences Inc 的預期收益為 $
RBC Life Sciences Inc 是否超出收益預期?
RBC Life Sciences Inc 最近的收益為 $, 預期。
關鍵數據
前收市價
$0.0007
開盤價
$0.0002
當日範圍
$0.0002 - $0.0007
52週區間
$0.0001 - $0.0007
交易量
2.1K
平均成交量
120
股息收益率
--
每股盈餘 (TTM)
-0.25
市值
$1.5K
什麼是 RBCL?
RBC Life Sciences, Inc. engages in the marketing and distribution of nutritional supplements and personal care products. The company is headquartered in Irving, Texas. The firm's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.